6558 — SYNergy ScienTech Income Statement
0.000.00%
- TWD2.49bn
- TWD2.11bn
- TWD1.20bn
- 84
- 22
- 55
- 55
Annual income statement for SYNergy ScienTech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,007 | 1,793 | 1,691 | 1,148 | 1,197 |
Cost of Revenue | |||||
Gross Profit | 466 | 340 | 277 | 109 | 167 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 1,795 | 1,689 | 1,662 | 1,271 | 1,260 |
Operating Profit | 212 | 103 | 29.1 | -122 | -63.6 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 205 | 78.1 | 5.75 | -86.2 | -45.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 162 | 62.4 | 3.28 | -61 | -44.7 |
Net Income Before Extraordinary Items | |||||
Net Income | 162 | 62.4 | 3.28 | -61 | -44.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 162 | 62.4 | 3.28 | -61 | -44.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.87 | 0.722 | 0.043 | -0.612 | -0.44 |
Dividends per Share |